This section offers news briefs on the pharmaceutical industry as of November 2011. Trans Nova Investments Ltd. will purchase all shares of Affitech A/S of Denmark for 0.0934 U.S. dollar per share. The drug application by Amarin Corp. plc of Ireland has been accepted by the U.S. Food and Drugs...
Pharmaceutical Company Round-up.//PharmaWatch: Monthly Review;Jan2009, Vol. 8 Issue 1, p3The article offers information related to pharmaceutical industry in the U.S. GlaxoSmithKline and Shenzhen Neptunus Interlong Bio-Technique have formed a joint venture which will focus solely on influenza vaccines. The Food and Drug Administration (FDA) has approved Eisai\'s Banzel for the...
Industry Outlook.Chatterjee, B.; Wong, W.//Pharmaceutical Processing;Jan2012, Vol. 27 Issue 1, p42The article presents an outlook for the pharmaceutical industry in 2012. It anticipates sustained market development in the emerging markets as various countries including Turkey, Egypt and Iran seek for position in the global marketplace. It also predicts the escalation of the U.S. Food and...
WEEK IN REVIEW.//BioWorld Insight;9/3/2013, Vol. 21 Issue 26, p5The article offers global news briefs of pharmaceutical industry as of September 3, 2013. Immune Pharmaceuticals Ltd. completed its merger with public company Epicept Corp. Qrxpharma Ltd. received Food and Drug Administration\'s (FDA) response letter for its pain treatment Moxduo. Ceptaris...
Sanofi Augments its Biosurgery Unit with Pluromed Acquisition.Cartwright, Heather//PharmaDeals Review;2012, Vol. 2012 Issue 3, p47Sanofi has agreed to buy the US medical device company Pluromed in order to strengthen the biosurgery portfolio it gained via its takeover of Genzyme in 2011. With the acquisition, Sanofi will gain Pluromed\'s biocompatible reverse thermosensitive polymer technology, Rapid Transition...
Collaborating on GMP Inspections.Milmo, Sean//Pharmaceutical Technology Europe;Sep2015, Vol. 27 Issue 9, p10The article reports on collaboration of European (EU) network of medicines regulatory agencies with the U.S. Food and Drug Administration (FDA) for improving good manufacturing practice (GMP) inspection. Topics discussed include need of EU-FDA deal in reduction of cost, avoiding of duplication,...
Inspections Gone Mad.//Pharmaceutical Technology;Apr2011, Vol. 35 Issue 4, p16The article presents cautionary tales related to the pharmaceutical industry in the U.S. One firm made a deal to purchase a pharmaceutical firm from another country, which its government prohibited the deal. An inspector from the Food and Drug Administration (FDA) had written a 483-observation...
Pharma--a bitter pill to swallow.Baker, John; Odriscoll, Cath//European Chemical News;12/6/2004, Vol. 81 Issue 2127, p20Discusses the structural problems experienced by the pharmaceutical industry. Information on global drug sales in 2003 according to figures by IMS Health; Views on the merger of several drug companies; Observations on drug approval by the U.S. Food and Drug Administration in 2003; Major...
2013 seen as a disappointing year for med-tech sector so far.FORD, OMAR//Medical Device Daily;9/11/2013, Vol. 17 Issue 175, p1The article presents the latest developments in the U.S. medical technologies sector based on the EP Vantage Medtech Half Year Review 2013 of \"Evaluate.\" The report notes the sector\'s disappointing performance, pointing out the slow mergers and acquisition activity, and the significant drop in...
Courtesy of your local library
Enter a library name or part of a name, city, state, or province.Or enter your postal code and country to search by location: (optional)
>>> 更多资讯详情请访问蚂蚁淘商城